CIK 0001104506
- Large accelerated filer
INSMED Inc
Sign in to watch- Ticker
- INSM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- Operating
- EIN
- 541972729
- Phone
- +1 908-977-9900
- Business address
- 700 US HIGHWAY 202/206, BRIDGEWATER, NJ, 08807
- 4 Open-market sale Chair and CEO sold 7,605 shares at $102.27 ($777,763)
- 4 Planned sale Chief Medical Officer sold 4,424 shares at an average $102.90 ($455,248)
- 4 Planned sale Chief Legal Officer sold 6,149 shares at $108.47 ($666,982)
- 4 Planned sale Chair and CEO sold 25,564 shares at an average $106.33 ($2,718,224)
- 4 Open-market sale Chief Financial Officer sold 8,272 shares at $116.18 ($961,041)
- 4 Grant or award Director acquired 3,305 shares (grant or award)
- 4 Open-market sale Chief Operating Officer sold 5,837 shares at $116.18 ($678,143)
- 4 Grant or award Director acquired 3,305 shares (grant or award)
- 4 Planned sale Chief Medical Officer sold 18,333 shares at an average $116.12 ($2,128,892)
- 4 Open-market sale Chief Legal Officer sold 4,109 shares at $116.18 ($477,384)
- 4 Grant or award Director acquired 3,305 shares (grant or award)
- 4 Grant or award Director acquired 3,305 shares (grant or award)
- 4 Grant or award Director acquired 3,305 shares (grant or award)
- 4 Grant or award Director acquired 3,305 shares (grant or award)
- 4 Open-market sale Chair and CEO sold 13,283 shares at $116.18 ($1,543,219)
- 4 Planned sale Chief Medical Officer sold 12,949 shares at an average $100.40 ($1,300,121)
- 4 Planned sale Chair and CEO sold 10,699 shares at an average $137.34 ($1,469,442)
- 4 Planned sale Chair and CEO sold 10,699 shares at an average $143.97 ($1,540,332)
- 4 Planned sale Chair and CEO sold 10,699 shares at an average $163.22 ($1,746,336)
- 4 Planned sale Chief Operating Officer sold 88,060 shares at an average $164.63 ($14,497,651)
Page 2 of 40 · 787 filings